Mark Smithyes joins Sunnybrook’s Medventions 2026 Lecture Series

 
 

This evening, Mark Smithyes, MBA, President of Janus Life Sciences Consulting, explores how reimbursement, health technology assessment and economic evidence influence medtech adoption and commercialization. Mark has spent more than 30 years in the life sciences and founded Janus in 2017. His session will help early-stage innovators understand what payers look for and start gathering the evidence they’ll need to make the case for their technology.

Sore Thumb

Your friendly neighbourhood agency.

Our tight-knit team crafts video and photo campaigns, branding, and websites to help growing businesses like yours look their best online.

https://www.sorethumb.ca
Next
Next

PitchForce Announces Mark Smithyes as Featured Guest Speaker at Upcoming Meeting